Suppr超能文献

澳大利亚内分泌外科医生指南AES06/01。全甲状腺切除术后甲状旁腺激素测量与早期出院:澳大利亚数据分析及管理建议

Australian Endocrine Surgeons Guidelines AES06/01. Postoperative parathyroid hormone measurement and early discharge after total thyroidectomy: analysis of Australian data and management recommendations.

出版信息

ANZ J Surg. 2007 Apr;77(4):199-202. doi: 10.1111/j.1445-2197.2007.04018.x.

Abstract

BACKGROUND

The risk of hypocalcaemia after thyroidectomy has traditionally mandated inpatient monitoring for signs and symptoms as well as frequent measurement of serum calcium levels. In recent years there has been much interest in the published work about the use of intact parathyroid hormone (PTH) to better predict hypocalcaemia after thyroidectomy. Although generally accurate, the use of intact parathyroid hormone in Australia has not become widespread. On behalf of the Australian Endocrine Surgeons an analysis of Australian data on the use of PTH levels to predict hypocalcaemia after thyroidectomy was carried out. The data were analysed with a view to making recommendations about the use of this test in clinical practice and the feasibility of achieving safe early discharge for patients.

METHODS

Four recently published or presented Australian studies on the use of early postoperative PTH levels after total or completion thyroidectomy to predict post-thyroidectomy hypocalcaemia were analysed. Patients were stratified into either normal or low PTH groups as defined by the normal ranges set by each laboratory and rates of hypocalcaemia were analysed.

RESULTS

A total of 458 patients were examined. Seventy-six per cent of the patients had PTH in the normal range and hypocalcaemia (serum-corrected calcium cCa(2+) < 2.00 mmol/L) occurred in 17.9% of patients. Sensitivity, specificity and positive predictive values of a normal postoperative PTH level as a predictor of normocalcaemia are 92.6, 70.7 and 92.3%, respectively. Low PTH as a predictor of hypocalcaemia is poor. The overall sensitivity, specificity and positive predictive values are 70.7, 92.6 and 71.6%, respectively.

CONCLUSION

Normal postoperative PTH levels accurately predict normocalcaemia after total or completion thyroidectomy. PTH levels should ideally be drawn 4 h postoperatively and patients with PTH in the normal range can be safely discharged on the first postoperative day. Use of oral calcium supplements, either as needed or routinely, will avoid mild symptoms that may develop in 7% without treatment.

摘要

背景

传统上,甲状腺切除术后发生低钙血症的风险要求对患者进行住院监测,观察症状体征,并频繁检测血清钙水平。近年来,已发表的关于使用完整甲状旁腺激素(PTH)来更好地预测甲状腺切除术后低钙血症的研究备受关注。尽管总体上较为准确,但完整甲状旁腺激素在澳大利亚的使用尚未广泛普及。代表澳大利亚内分泌外科医生,对澳大利亚关于使用PTH水平预测甲状腺切除术后低钙血症的数据进行了分析。分析这些数据的目的是就该检测在临床实践中的应用以及实现患者安全早期出院的可行性提出建议。

方法

分析了四项最近发表或展示的澳大利亚研究,这些研究探讨了全甲状腺切除或甲状腺次全切除术后早期PTH水平用于预测甲状腺切除术后低钙血症的情况。根据各实验室设定的正常范围,将患者分为PTH正常组或低PTH组,并分析低钙血症的发生率。

结果

共检查了458例患者。76%的患者PTH在正常范围内,17.9%的患者发生了低钙血症(血清校正钙cCa(2+) < 2.00 mmol/L)。术后PTH水平正常作为血钙正常预测指标的敏感性、特异性和阳性预测值分别为92.6%、70.7%和92.3%。低PTH作为低钙血症的预测指标效果不佳。总体敏感性、特异性和阳性预测值分别为70.7%、92.6%和71.6%。

结论

术后PTH水平正常可准确预测全甲状腺切除或甲状腺次全切除术后的血钙正常情况。理想情况下,应在术后4小时检测PTH水平,PTH在正常范围内的患者可在术后第一天安全出院。根据需要或常规使用口服钙剂,可避免7%未经治疗可能出现的轻微症状。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验